rflrob
Joined 18 years ago
Joined 18 years ago
It's not clear that we have the health infrastructure in place to know what to do with frequent, low resolution, whole body scans of the human body. How often do anomalies show up and then go away? How often are anomalies purely a scanning/data processing artifact? Who reads the scans and makes recommendations about follow-ups, if any? I think this is the kind of thing that sounds exciting and with low direct risk, but with all kinds of questions that are not only unanswered, but apparently unconsidered.
https://en.wikipedia.org/wiki/Historical_rankings_of_preside...
A radiotropic fungus that’s in TFA can’t meaningfully affect the rate at which nuclear decay is happening. What it can do, supposedly, is to harvest the energy that the nuclear decay is releasing; normally there’s too much energy for an organism to safely handle.
At the risk of vastly oversimplifying, you can’t plug your phone into high voltage transmission lines. These fungi are using melanin to moderate the extra energy, stepping it down into a range that’s useful (or at least minimally harmful).
Yes, some people have more money than they know what to do with (and, I would argue, than is good for them or us), but I've seen no reasonable suggestions that as many of us can have what we want without a reasonably open market economy. I don't think we're at a local optimum in the fine details of the rules for that economy, but I don't think moving to a whole different part of the possibility space is likely to be better than where we are now.
Transmission of cancer is rare in humans—if it were not, it would make someone’s career to find many cases of it. While we can’t say that all sheep are white, we’ve looked at enough of them to say that black sheep are not common. Furthermore, it’s very clear how the Tasmanian devil cancer is spread—it’s around the mouth while they are biting each others faces; it’s not as obvious how one would spread most human cancers.
It might still be useful to know you have weird protease activity that isn’t cancer derived, but the more of these tests we do, the more likely it is that for every person, there’ll be at least one non-cancer oddity that looks like cancer signal for at least some test.
Just to be clear, most drug trials for anything where we have an effective treatment are not “new drug vs placebo”, but instead “new drug vs standard of care”. Thus the goal being to prove it’s better than what already exists.
On the other hand, if the butterfly is eating the nectar and the pollination is an ancillary effect, then you have to start invoking more complicated mechanisms. Maybe successful pollination of the plants increases the food supply later? Maybe the flowers are not neutrally charged, but instead become oppositely charged when the pollen is ready to bias pollinators to come close at appropriate times? You can always construct some just-so story that fits the observed evidence, but where it becomes science is when you make predictions and test them.
My concern would be that the team would cut safety corners until the probability of success just barely rises above some threshold, rather than engineering everything to have as low a risk as is feasible. Is 0-1atm easier than 1-infinity atm? Yes, but that just means you can cut more corners.
https://en.m.wikipedia.org/wiki/1954_Guatemalan_coup_d%2527%...